Genetic Determinants Involved in the Susceptibility of Pseudomonas aeruginosa to β-Lactam Antibiotics

被引:130
作者
Alvarez-Ortega, Carolina [1 ,2 ]
Wiegand, Irith [3 ]
Olivares, Jorge [1 ,2 ]
Hancock, Robert E. W. [3 ]
Luis Martinez, Jose [1 ,2 ]
机构
[1] CSIC, Dept Biotecnol Microbiana, Ctr Nacl Biotecnol, Madrid, Spain
[2] CIBERESP, Madrid, Spain
[3] Univ British Columbia, Dept Microbiol & Immunol, Ctr Microbial Dis & Immun Res, Vancouver, BC V6T 1Z4, Canada
关键词
CYSTIC-FIBROSIS PATIENTS; RESISTANCE MECHANISMS; ESCHERICHIA-COLI; BIOCHEMICAL-CHARACTERIZATION; MUTANT LIBRARY; CELL-DIVISION; MEXAB-OPRM; MEXCD-OPRJ; EXPRESSION; AMPC;
D O I
10.1128/AAC.00257-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The resistome of P. aeruginosa for three beta-lactam antibiotics, namely, ceftazidime, imipenem, and meropenem, was deciphered by screening a comprehensive PA14 mutant library for mutants with increased or reduced susceptibility to these antimicrobials. Confirmation of the phenotypes of all selected mutants was performed by Etest. Of the total of 78 confirmed mutants, 41 demonstrated a reduced susceptibility phenotype and 37 a supersusceptibility (i.e., altered intrinsic resistance) phenotype, with 6 mutants demonstrating a mixed phenotype, depending on the antibiotic. Only three mutants demonstrated reduced (PA0908) or increased (glnK and ftsK) susceptibility to all three antibiotics. Overall, the mutant profiles of susceptibility suggested distinct mechanisms of action and resistance for the three antibiotics despite their similar structures. More detailed analysis indicated important roles for novel and known beta-lactamase regulatory genes, for genes with likely involvement in barrier function, and for a range of regulators of alginate biosynthesis.
引用
收藏
页码:4159 / 4167
页数:9
相关论文
共 65 条
[1]   Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and β-lactamase and alginate production [J].
Bagge, N ;
Schuster, M ;
Hentzer, M ;
Ciofu, O ;
Givskov, M ;
Greenberg, EP ;
Hoiby, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) :1175-1187
[2]   Crystal Structure of the AmpR Effector Binding Domain Provides Insight into the Molecular Regulation of Inducible AmpC β-Lactamase [J].
Balcewich, Misty D. ;
Reeve, Thomas M. ;
Orlikow, Evan A. ;
Donald, Lynda J. ;
Vocadlo, David J. ;
Mark, Brian L. .
JOURNAL OF MOLECULAR BIOLOGY, 2010, 400 (05) :998-1010
[3]   Comparison of the Micronaut Merlin automated broth microtiter system with the standard agar dilution method for antimicrobial susceptibility testing of mucoid and nonmucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients [J].
Balke, B ;
Hoy, L ;
Weissbrodt, H ;
Häussler, S .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (10) :765-771
[4]   Low-level antibacterial resistance: a gateway to clinical resistance [J].
Baquero, F .
DRUG RESISTANCE UPDATES, 2001, 4 (02) :93-105
[5]  
Baquero F, 1998, Int Microbiol, V1, P295
[6]   PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa [J].
Blazquez, Jesus ;
Gomez-Gomez, Jose-Maria ;
Oliver, Antonio ;
Juan, Carlos ;
Kapur, Vivek ;
Martin, Soledad .
MOLECULAR MICROBIOLOGY, 2006, 62 (01) :84-99
[7]   Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA [J].
Boucher, JC ;
MartinezSalazar, J ;
Schurr, MJ ;
Mudd, MH ;
Yu, H ;
Deretic, V .
JOURNAL OF BACTERIOLOGY, 1996, 178 (02) :511-523
[8]   Complex Ciprofloxacin Resistome Revealed by Screening a Pseudomonas aeruginosa Mutant Library for Altered Susceptibility [J].
Breidenstein, Elena B. M. ;
Khaira, Bhavjinder K. ;
Wiegand, Irith ;
Overhage, Joerg ;
Hancock, Robert E. W. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (12) :4486-4491
[9]   MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa:: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719 [J].
Cao, L ;
Srikumar, R ;
Poole, K .
MOLECULAR MICROBIOLOGY, 2004, 53 (05) :1423-1436
[10]   The pharmacology of meropenem, a new carbapenem antibiotic [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S266-S275